Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: pertuzumab|BIOLOGICAL: trastuzumab
Sponsor: National Institutes of Health Clinical Center (CC)
Collaborators: National Cancer Institute (NCI)